globenewswire

TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 10:00
NEW YORK--TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael Weiss, the Company's Interim Chief Executive Officer, will be presenting at the 16th Annual BIO CEO & Investor Conference being held at the Waldorf Astoria Hotel in New York City.
Read more...
 
21st Century Oncology Promotes Bryan J. Carey to President Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 09:35
FORT MYERS, Fla.--21st Century Oncology Holdings, Inc. ("21st Century Oncology" or "the Company"), the largest global, physician led provider of integrated cancer care services, announced today the promotion of Bryan J. Carey to President, in addition to his continuing responsibilities as Chief Financial Officer.
Read more...
 
Baxano Surgical Sets Date of 2014 Annual Meeting Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 06:30
RALEIGH, N.C.--Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced that it will be holding its Annual Meeting of Stockholders on Thursday, April 17, 2014.
Read more...
 
OncoMed Pharmaceuticals, Inc. [OMED] to Ring The NASDAQ Stock Market Closing Bell Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 04:00
ADVISORY--What:  OncoMed Pharmaceuticals, Inc. [OMED], a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, will visit the NASDAQ MarketSite in Times Square.
Read more...
 
Southeast Alabama Medical Center Joins Premier, Inc.'s Quality Improvement Collaborative Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 03:09
CHARLOTTE, N.C.--Southeast Alabama Medical Center (SAMC) of Dothan, Alabama has joined Premier, Inc.'s QUEST® collaborative of nearly 350 providers that are setting new standards of healthcare excellence.
Read more...
 
NovaBay Pharmaceuticals to Present at the Annual Dialysis Conference in Atlanta Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 02:30
EMERYVILLE, Calif.--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that NovaBay will have a booth at the Annual Dialysis Conference, held February 8-11, 2014 in Atlanta, GA.
Read more...
 
IPC The Hospitalist Company to Report Fourth Quarter and Full Year 2013 Financial Results Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 02:30
NORTH HOLLYWOOD, Calif.--IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, will report its financial results for the fourth quarter and full year ended Dec. 31, 2013 on Thursday, Feb. 20, 2014, after the market close.
Read more...
 
TESARO to Announce Fourth Quarter 2013 Financial Results on February 19, 2014 Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 02:01
WALTHAM, Mass.--TESARO, Inc. (Nasdaq:TSRO) will announce its fourth quarter 2013 financial results on Wednesday, February 19, 2014, after the close of the U.S. financial markets.
Read more...
 
Novelos Therapeutics Announces Closing of $4.0 Million Private Placement Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 01:30
MADISON, Wis.--Novelos Therapeutics, Inc. (OTCQX:NVLT) a pharmaceutical company developing novel agents for the treatment and diagnosis of cancer, is pleased to announce that it has closed the previously disclosed non-brokered private placement of two-year, 8% convertible debentures and warrants, raising gross proceeds of $4.0 million.
Read more...
 
BRCA Patent Owners and Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 01:00
HOUSTON and SALT LAKE CITY--Gene by Gene, Ltd. and Myriad Genetics, Inc., the University of Utah Research Foundation, HSC Research and

Error. Page cannot be displayed. Please contact your service provider for more details. (24)

Development Limited Partnership, Endorecherche, Inc., and the Trustees of the University of Pennsylvania (the "Patent Owners") have reached an agreement to settle the patent infringement lawsuit between them regarding BRCA testing.
Read more...
 
Vical to Present at the 2014 Leerink Global Healthcare Conference Print E-mail
By GLOBE NEWSWIRE   
Friday, 07 February 2014 00:30
SAN DIEGO--Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on Thursday, February 13, at 3:30 p.m. ET at the 2014 Leerink Global Healthcare Conference (New York City, February 12 – 13).
Read more...
 
Five Prime Therapeutics Prices Public Offering of Common Stock Print E-mail
By GLOBE NEWSWIRE   
Thursday, 06 February 2014 17:18
SOUTH SAN FRANCISCO, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE)
Read more...
 
Ekso Bionics(TM) Completes Private Placement, Raising $30.3M Print E-mail
By GLOBE NEWSWIRE   
Thursday, 06 February 2014 14:01
RICHMOND, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE)
Read more...
 
Swisher Hygiene Inc. Announces Settlement of U.S. Class Action Lawsuits Print E-mail
By GLOBE NEWSWIRE   
Thursday, 06 February 2014 11:20
CHARLOTTE, N.C.--Swisher Hygiene Inc. ("Swisher") (Nasdaq:SWSH) (TSX:SWI), a leading provider of essential hygiene and sanitizing products and services, announced today that it has entered into a Stipulation of Compromise and Settlement (the "Settlement") with the Lead Plaintiffs in the consolidated class action lawsuits filed in the U.S. against the Company. Pursuant to the Settlement, which remains subject to Court approval, the Company has agreed to pay $5.5 million (the "Settlement Payment") to a Settlement Fund.
Read more...
 
Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2014 Financial Results Print E-mail
By GLOBE NEWSWIRE   
Thursday, 06 February 2014 11:19
MORRIS PLAINS, N.J.--Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a conference call and live audio webcast on Tuesday, February 11, 2014 at 10:00 a.m. Eastern Time to discuss financial results for the second quarter of fiscal year 2014, and review key clinical developments and future planned activities.
Read more...
 
<< Start < Prev 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 Next > End >>

Page 1453 of 1497

Newsletter

BMR:1